cholestyramine resin has been researched along with Brain Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hope, BE; Hope, JH | 1 |
| Koopman, BJ; Van den Brekel, HW; Waterreus, RJ; Wolthers, BG | 1 |
| Grundy, SM; Salen, G | 1 |
1 review(s) available for cholestyramine resin and Brain Disorders
| Article | Year |
|---|---|
A review of the diagnosis and treatment of Ochratoxin A inhalational exposure associated with human illness and kidney disease including focal segmental glomerulosclerosis.
Topics: Animals; Anion Exchange Resins; Aspergillus; Brain Diseases; Breast Feeding; Carcinogens; Child, Preschool; Cholestyramine Resin; Female; Glomerulosclerosis, Focal Segmental; Humans; Inhalation Exposure; Kidney Diseases; Mice; Middle Aged; Ochratoxins; Penicillium; Pregnancy; Pregnancy Complications; Rabbits; Rats | 2012 |
2 other study(ies) available for cholestyramine resin and Brain Disorders
| Article | Year |
|---|---|
Detection of carriers of cerebrotendinous xanthomatosis.
Topics: Adolescent; Adult; Brain Diseases; Child; Cholestanols; Cholestyramine Resin; Female; Genetic Carrier Screening; Humans; Male; Middle Aged; Muscular Diseases; Tendons; Xanthomatosis | 1986 |
The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
Topics: Adult; Aged; Bile Acids and Salts; Brain Diseases; Carbon Radioisotopes; Cholestanol; Cholesterol; Cholestyramine Resin; Clofibrate; Diet; Esters; Feces; Female; Humans; Injections, Intravenous; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Tendons; Tritium; Xanthomatosis | 1973 |